Cargando…
Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine development
BACKGROUND: To screen efficacious neoantigens for the development of LIHC mRNA vaccines, construct LIHC immune clusters, and therefore select patients who might benefit from vaccination. METHODS: RNA-seq data and clinical information of 371 TCGA-LIHC and 231 ICGC-LIHC cohorts were downloaded. Differ...
Autores principales: | Li, Yi-Fei, Hou, Qiong-Qiong, Zhao, Shuang, Chen, Xiaoyan, Tang, Min, Li, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561321/ https://www.ncbi.nlm.nih.gov/pubmed/36239794 http://dx.doi.org/10.1007/s00432-022-04285-7 |
Ejemplares similares
-
Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma
por: Chen, Pu, et al.
Publicado: (2021) -
Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression
por: Nguyen, Kim Bich, et al.
Publicado: (2023) -
Neoantigens as potential vaccines in hepatocellular carcinoma
por: Repáraz, David, et al.
Publicado: (2022) -
Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin
por: Wang, Xiumei, et al.
Publicado: (2020) -
Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development
por: Lu, Tai-Liang, et al.
Publicado: (2023)